Bruce W. Konicek - Concepedia

Author

Bruce W. Konicek

Also Known As

B Konicek, B W Konicek, B. Konicek, B.W. Konicek, BRUCE W. KONICEK, Bruce Konicek, Bruce W Konicek, Bruce W. Konicek, Bruce W. Konicek

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)McGill University

About

Bruce W. Konicek is an author at Eli Lilly (United States) specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.1K
2	Cell Biology	8	8	1.1K
3	Immunology	2	2	209
4	Natural Sciences	1	1	75
5	Pathology	1	1	171

Bruce W. Konicek

Publications

Citations

H-Index

Page 1

	Year	Citations
The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts Jeremy R. Graff, Ann M. McNulty, Kimberly R. Hanna, Cancer Research	2005	435
Increased AKT Activity Contributes to Prostate Cancer Progression by Dramatically Accelerating Prostate Tumor Growth and Diminishing p27Kip1 Expression Jeremy R. Graff, Bruce W. Konicek, Ann M. McNulty, Journal of Biological Chemistry	2000	380
Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity Jeremy R. Graff, Bruce W. Konicek, Thomas M. Vincent, Journal of Clinical Investigation Tumor BiologyTherapeutic SuppressionMedicineTumor GrowthEif4e Mrna	2007	375
Pharmacogenetic Inhibition of eIF4E-Dependent Mmp9 mRNA Translation Reverses Fragile X Syndrome-like Phenotypes Christos G. Gkogkas, Arkady Khoutorsky, Ruifeng Cao, Cell Reports	2014	198
eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival Jeremy R. Graff, Bruce W. Konicek, Rebecca L. Lynch, Cancer Research Eif4e ActivationUrologyGenitourinary CancerReduced Patient SurvivalMedicine	2009	197
Therapeutic Inhibition of MAP Kinase Interacting Kinase Blocks Eukaryotic Initiation Factor 4E Phosphorylation and Suppresses Outgrowth of Experimental Lung Metastases Bruce W. Konicek, Jennifer R. Stephens, Ann M. McNulty, Cancer Research Bioavailable Mnk InhibitorCancer BiologyTumor BiologySignaling PathwayCell Regulation	2011	187
Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. Melvyn A. Harrington, Bruce W. Konicek, An Song, Journal of Biological Chemistry SclerostinPromoter ActivityGeneticsImmunologyPathology	1993	171
LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models S. Betty Yan, Victoria L. Peek, Rose T. Ajamie, Investigational New Drugs	2012	159
AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon. Michael Zinda, Mac Johnson, Joshua Paul, PubMed	2001	150
Integrin-linked kinase expression increases with prostate tumor grade. Jeremy R. Graff, James A. Deddens, Bruce W. Konicek, PubMed	2001	138

Page 1